Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation
about
Immune response to HHV-6 and implications for immunotherapyAntiviral T-cell therapySystemic inflammatory response syndrome after administration of unmodified T lymphocytes.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Inhibition of breast cancer cell proliferation through disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument proteinRapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.Laboratory and clinical aspects of human herpesvirus 6 infections.Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6BT cells for viral infections after allogeneic hematopoietic stem cell transplantDevelopment of gene therapy for blood disorders: an update.BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation.Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.Roseola infantum and its causal human herpesviruses.The development of new therapies for human herpesvirus 6.Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation.Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.Characterizing the Cellular Immune Response to Parainfluenza Virus 3.Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90.Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes.Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.CD8(+) T Cells Prevent Lethality from Neonatal Murine Roseolovirus Infection.Virus-Specific T Cells for the Immunocompromised Patient.Asian elephant T cell responses to Elephant Endotheliotropic Herpesvirus (EEHV).Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6.
P2860
Q26827409-A3478124-0DB2-4297-81D0-61718740D2BDQ27028006-25915967-D619-4DF2-A72D-1A3FF102BB2DQ33724261-8FC67042-B498-4CD9-935A-4EB14DF88EE0Q33897804-7B291E56-3298-485F-AFDC-DCB65A580A4EQ34273968-8479381C-7942-4A82-868F-EAF7F9CA8010Q34593618-36ECBC5C-7E9E-4DFD-91B1-9555592B928AQ35104509-CB6A7FB4-452A-456E-9C92-E449662C0FD4Q35482603-51846672-BF71-46E3-BBF5-CF3CF253D8F3Q35849274-1F3865A8-A2B4-41BE-BFC4-455B1A3C5F31Q35850475-43FC1EB2-0E12-4EFE-BFC2-7ACB6987F0FEQ37058107-340D71E2-C849-4E78-B341-DD1E5B7ED09DQ37132611-B0B832B9-63DE-4C7A-BAF1-EDC19A59DE4FQ37174366-D4DD44B8-2AFF-4D03-91EB-ED450FB28EE0Q37547414-C652D15F-4B57-47BE-8685-BF909A12C2A0Q38199720-371242F5-7D7D-486B-9BA2-3071A2024C73Q38280949-608760F6-B086-44DC-96A5-5AAFEAD11932Q38797555-A5911FD1-BF6A-4072-ABC9-27FF95C5A5FEQ38930292-141F3605-50DE-4CB1-BD8B-3635BCD6687BQ40092234-A44D58B4-4BBA-4F50-85F0-7A6141727825Q40215048-7DC456C1-F6A4-412B-B7EB-61B7E59B8890Q40884483-F5DA28E5-B9CC-4A5D-A7AC-65C9F28928C9Q41730520-2CF842D0-D9F5-4A14-92CB-3B4C792ED4EAQ41807836-675CC4EA-23AB-492B-BE04-66BFDFC3BC25Q41925665-E3804B95-B5AD-4CFB-A334-58ECC13DDA0EQ42654381-635953C5-8376-4488-8DA6-E88EB884A5D6Q47269094-A97B1251-82C8-41B1-B1B8-AA65AD5E89C5Q55342452-A5EE532D-65A7-41FA-B7F4-6DC9A3D95FB2Q55516321-279875A2-2452-481A-B43F-15168E737FB5
P2860
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Immunotherapeutic strategies t ...... neic stem cell transplantation
@en
Immunotherapeutic strategies t ...... eic stem cell transplantation.
@nl
type
label
Immunotherapeutic strategies t ...... neic stem cell transplantation
@en
Immunotherapeutic strategies t ...... eic stem cell transplantation.
@nl
prefLabel
Immunotherapeutic strategies t ...... neic stem cell transplantation
@en
Immunotherapeutic strategies t ...... eic stem cell transplantation.
@nl
P2093
P2860
P1433
P1476
Immunotherapeutic strategies t ...... neic stem cell transplantation
@en
P2093
Alana Kennedy-Nasser
Ann M Leen
Anne P de Pagter
Chinh T Q Nguyen
Cliona M Rooney
Helen E Heslop
Jacqueline M Keirnan
Laura Keukens
Malcolm K Brenner
Stephen M Gottschalk
P2860
P304
P356
10.1182/BLOOD-2012-05-430413
P407
P577
2012-11-14T00:00:00Z